XML 66 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Revenues, Uranium Concentrates $ 0 $ 66 $ 30,789
Revenues, Vanadium Concentrates 0 2,237 0
Revenues, Alternate Feed Materials Processing and Other 1,658 3,562 932
Revenues 1,658 5,865 31,721
Cost of Revenue, Uranium Concentrates 0 63 14,752
Cost of Revenue, Applicable To Vanadium Concentrates 0 1,805 0
Cost of Revenue, Alternate Feed Materials and Other 0 2,079 0
Uranium concentrates 0 3,947 14,752
Impairment of inventories 1,644 14,351 4,579
Development, Permitting And Land Holding 4,333 9,180 9,912
Standby costs 4,015 2,584 5,112
Accretion of asset retirement obligation 1,911 1,931 1,835
Selling costs 38 190 183
Intangible asset amortization 0 0 2,502
General and administration 14,344 14,263 14,158
Total operating loss (24,627) (40,581) (21,312)
Interest expense (952) (1,491) (1,722)
Other Nonoperating Income (Expense) (2,293) 3,978 (2,328)
Net loss (27,872) (38,094) (25,362)
Items that may be reclassified in the future to profit and loss      
Foreign currency translation adjustment (681) (854) 1,554
Other comprehensive income (loss) (681) (854) 1,554
Comprehensive loss (28,553) (38,948) (23,808)
Net loss attributable to:      
Owners of the Company (27,776) (37,978) (25,245)
Non-controlling interests (96) (116) (117)
Net loss (27,872) (38,094) (25,362)
Comprehensive loss attributable to:      
Owners of the Company (28,457) (38,832) (23,691)
Non-controlling interests (96) (116) (117)
Comprehensive loss $ (28,553) $ (38,948) $ (23,808)
Basic and diluted loss per share (Note 8) (in USD per share) $ (0.23) $ (0.40) $ (0.30)